| Dabigatran etexilate. | |
| | |
MedLine Citation:
|
PMID: 20642542 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Eline A Dubois; Adam F Cohen |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: British journal of clinical pharmacology Volume: 70 ISSN: 1365-2125 ISO Abbreviation: Br J Clin Pharmacol Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-20 Completed Date: 2011-02-24 Revised Date: 2011-08-01 |
Medline Journal Info:
|
Nlm Unique ID: 7503323 Medline TA: Br J Clin Pharmacol Country: England |
Other Details:
|
Languages: eng Pagination: 14-5 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
therapeutic use* Benzimidazoles / adverse effects, economics, pharmacology* Humans Pyridines / adverse effects, economics, pharmacology* Thrombin / antagonists & inhibitors* Venous Thromboembolism / prevention & control |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Benzimidazoles; 0/Pyridines; 211915-06-9/dabigatran etexilate; EC 3.4.21.5/Thrombin |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A manifesto for clinical pharmacology from principles to practice.
Next Document: Drug- and non-drug-associated QT interval prolongation.